0001144204-14-073758.txt : 20141212 0001144204-14-073758.hdr.sgml : 20141212 20141212170053 ACCESSION NUMBER: 0001144204-14-073758 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20141212 FILED AS OF DATE: 20141212 DATE AS OF CHANGE: 20141212 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Mindray Medical International LTD CENTRAL INDEX KEY: 0001373060 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-33036 FILM NUMBER: 141284270 BUSINESS ADDRESS: STREET 1: MINDRAY BUILDING, KEJI 12TH ROAD SOUTH STREET 2: HI-TECH INDUSTRIAL PARK, NANSHAN CITY: SHENZHEN STATE: F4 ZIP: 518057 BUSINESS PHONE: (86)-755-2658-2888 MAIL ADDRESS: STREET 1: MINDRAY BUILDING, KEJI 12TH ROAD SOUTH STREET 2: HI-TECH INDUSTRIAL PARK, NANSHAN CITY: SHENZHEN STATE: F4 ZIP: 518057 6-K 1 v396401_6k.htm 6-K

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

 

 

 

Form 6-K

 

 

 

REPORT OF FOREIGN ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 OF

THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of December 2014

 

Commission File Number: 001-33036

 

 

 

Mindray Medical International Limited

 

 

 

Mindray Building, Keji 12th Road South,

Hi-tech Industrial Park, Nanshan,

Shenzhen 518057

People’s Republic of China

(Address of principal executive office)

 

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

 

Form 20-F  x            Form 40-F  ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ¨

 

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

 

Yes  ¨            No  x

 

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): N/A

 

 

 

 
 

 

Mindray Medical International Limited (“Mindray”) today announced shareholder resolutions adopted at its annual general meeting of shareholders held in Hong Kong on December 10, 2014

 

At the meeting, Mindray shareholders voted to re-elect incumbent directors Li Xiting and Kern Lim, each to serve a three-year term. Mindray’s shareholders did not re-elect Peter Wan as a director.

 

In addition, Mindray shareholders ratified the appointment of PricewaterhouseCoopers as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2014.

 

 
 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Mindray Medical International Limited  
       
By: /s/ Alex Lung  
  Name: Alex Lung  
  Title: Chief Financial Officer  

 

Date: December 12, 2014